Venetoclax

Back to search

Molecule Structure

Scientific Name

Venetoclax

Description of the Drug

Venetoclax is a BCL-2 inhibitor used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11581

Brand Name(s)

Venclexta

Company Owner(s)

Abbvie Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Apoptosis regulator Bcl-2 SINGLE PROTEIN INHIBITOR CHEMBL4860

Unichem Links

SureChEMBL SCHEMBL523816
PharmGKB PA166153473
Human Metabolome Database HMDB0247760
DrugBank DB11581
PubChem: Thomson Pharma 104174762
PubChem 49846579
LINCS LSM-45468
PDBe LBM
BindingDB 60828 50162774
EPA CompTox Dashboard DTXSID30154863
DrugCentral 5133
ChemicalBook CB73339265 CB62645962
Guide to Pharmacology 8318
rxnorm VENETOCLAX VENCLEXTA
ChEBI 133021
ZINC ZINC000150338755